Details for Patent: 11,083,724
✉ Email this page to a colleague
Which drugs does patent 11,083,724 protect, and when does it expire?
Patent 11,083,724 protects NURTEC ODT and is included in one NDA.
This patent has fifteen patent family members in thirteen countries.
Summary for Patent: 11,083,724
| Title: | Rimegepant for CGRP related disorders |
| Abstract: | Disclosed are methods of treating CGRP related disorders, e.g., migraine, by administering to a patient in need thereof rimegepant or a pharmaceutically acceptable salt thereof. Pharmaceutical compositions comprising rimegepant and kits including the pharmaceutical compositions and instructions are also disclosed. |
| Inventor(s): | Coric; Vladimir (Madison, CT), Croop; Robert (Newton Square, PA) |
| Assignee: | Biohaven Pharmaceutical Ireland DAC (Dublin, IE) |
| Application Number: | 16/884,196 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Dosage form; |
Drugs Protected by US Patent 11,083,724
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | NURTEC ODT | rimegepant sulfate | TABLET, ORALLY DISINTEGRATING;ORAL | 212728-001 | Feb 27, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ACUTE TREATMENT OF MIGRAINE WITH OR WITHOUT AURA IN ADULTS | ⤷ Try a Trial | |||
| Pfizer | NURTEC ODT | rimegepant sulfate | TABLET, ORALLY DISINTEGRATING;ORAL | 212728-001 | Feb 27, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | PREVENTIVE TREATMENT OF EPISODIC MIGRAINE IN ADULTS | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,083,724
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2019242604 | ⤷ Try a Trial | |||
| Brazil | 112020019396 | ⤷ Try a Trial | |||
| Canada | 3094693 | ⤷ Try a Trial | |||
| China | 112153969 | ⤷ Try a Trial | |||
| Eurasian Patent Organization | 202092278 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
